Maxwell MRI

Maxwell Plus operates in the healthcare sector, specializing in prostate cancer testing for men across Australia. The company leverages advanced artificial intelligence (AI) technology to assist specialist clinicians in reviewing test results and providing accurate, early detection of prostate cancer. Clients include men who have been previously tested and those new to testing, with no referral required. The service is primarily conducted online through a secure application, where patients can complete assessments, receive digital test requests, and access clinical recommendations. Maxwell Plus partners with over 2,500 testing facilities across Australia to facilitate blood tests. The business model is based on providing a subscription-based service that ensures continuous monitoring and timely medical advice. Revenue is generated through subscription fees and partnerships with healthcare providers.

Keywords: prostate cancer, AI technology, online healthcare, early detection, specialist clinicians, digital test requests, secure application, subscription service, Australian market, medical assessments.